Last update :
23/04/2025
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
valistab
valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Sympathomimetic   Epinephrine hydrochloride  
injection
Ointments
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Adrenalin Canada, Denmark, Finland, Germany, Iceland, Luxembourg, Norway, Spain, Sweden, Switzerland, Turkey
Adrenalina Argentina, Brazil, Colombia, Ecuador, Italy, Portugal, Romania, Spain
Adrenaline Australia, Austria, Belgium, Egypt, France, New Zealand, Saudi Arabia, United Arab Emirates
Anapen Austria, Canada, Egypt, France, Germany, Great Britain, Netherlands, Sweden, Switzerland
Emerade Croatia, Denmark, Finland, France, Germany, Great Britain, Italy, Norway, Spain, Sweden
Epipen Argentina, Austria, Belgium, Canada, Chile, Croatia, Denmark, Finland, France, Germany, Great Britain, Hungary, Iceland, Iran, Ireland, Japan, Malaysia, Netherlands, New Zealand, Norway, Romania, Slovenia, Sweden, Switzerland, United States of America
Levophed Belgium, Canada, Greece, Luxembourg, New Zealand, Saudi Arabia, United Arab Emirates, United States of America
Levopress Venezuela
Pinadrina Mexico
Suprarenin Austria, Finland, Germany
Tonogen Hungary, Italy
Vasocon Belgium, Brazil, Chile, France, India, Luxembourg, Malaysia, Spain, United States of America
Stability in solutions   injection   Stability in solutions : Epinephrine hydrochloride     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass Water for Injection 100 µg/ml 25°C Protect from light
7 Day
659
Level of evidence B
Glass Water for Injection 100 µg/ml 25°C Protect from light
7 Day
659
Level of evidence B
Glass Water for Injection 700 µg/ml 25°C Protect from light
56 Day
659
Level of evidence B
Glass Water for Injection 700 µg/ml 25°C Protect from light
56 Day
659
Level of evidence B
Polyvinyl chloride Sodium chloride 0,9% 16 µg/ml 23-25°C Light
45 Day
4026
Level of evidence D
Polyvinyl chloride Sodium chloride 0,9% 16 µg/ml 3-5°C Protect from light
60 Day
4026
Level of evidence D
Polyvinyl chloride Sodium chloride 0,9% 64 µg/ml 23-25°C Light
45 Day
4026
Level of evidence D
Polyvinyl chloride Sodium chloride 0,9% 64 µg/ml 3-5°C Protect from light
60 Day
4026
Level of evidence D
Polyvinyl chloride Glucose 5% 100 µg/ml 23°C Protect from light
24 Hour
192
Level of evidence B
Polyvinyl chloride Glucose 5% 16 µg/ml 5°C Protect from light
20 Day
197
Level of evidence D
Polypropylen Syringe Water for Injection 100 µg/ml 25°C Protect from light
7 Day
659
Level of evidence B
Polypropylen Syringe Water for Injection 700 µg/ml 25°C Protect from light
56 Day
659
Level of evidence B
Polypropylen Syringe NaCl 0,9% or Glucose 5% 20 µg/ml 23°C Not specified
84 Hour
3712
Level of evidence D
Polypropylen Syringe NaCl 0,9% or Glucose 5% 300 µg/ml 23°C Not specified
84 Hour
3712
Level of evidence D
Polypropylen Syringe NaCl 0,9% or Glucose 5% 900 µg/ml 23°C Not specified
84 Hour
3712
Level of evidence D
Polypropylen Syringe Sodium chloride 0,9% 10 µg/ml 2-8°C Protect from light
90 Day
4323
Level of evidence C
Polypropylen Syringe Sodium chloride 0,9% 10 µg/ml 20-25°C Protect from light
12 Day
4778
Level of evidence C
Polypropylen Syringe Sodium chloride 0,9% 10 µg/ml 25°C Not specified
21 Day
4393
Level of evidence D
conflicting data
Polypropylen Syringe Sodium chloride 0,9% 10 µg/ml 4°C Not specified
56 Day
4393
Level of evidence D
conflicting data
Polypropylen Syringe Sodium chloride 0,9% 10 µg/ml 4°C Protect from light
56 Day
4778
Level of evidence C
Polypropylen Syringe Glucose 5% 20 µg/ml 2-8°C Protect from light
183 Day
3445
Level of evidence B
Polypropylen Syringe Glucose 5% 20 µg/ml 2-8°C Protect from light
180 Day
3397
Level of evidence B
Polypropylen Syringe Glucose 10% 20 µg/ml 23°C Not specified
84 Hour
3712
Level of evidence D
Polypropylen Syringe Glucose 10% 300 µg/ml 23°C Not specified
84 Hour
3712
Level of evidence D
Polypropylen Syringe Glucose 10% 900 µg/ml 23°C Not specified
84 Hour
3712
Level of evidence D
syringe polycarbonate Water for Injection 100 µg/ml 2-8°C Protect from light
172 Day
3309
Level of evidence A+
Not specified Glucose 5% 100 µg/ml 25°C Protect from light
30 Day
3704
Level of evidence C
Not specified Glucose 5% 100 µg/ml 4°C Protect from light
30 Day
3704
Level of evidence C
Not specified Glucose 5% 25 µg/ml 25°C Protect from light
30 Day
3704
Level of evidence C
Not specified Glucose 5% 25 µg/ml 4°C Protect from light
30 Day
3704
Level of evidence C
Not specified Glucose 5% 50 µg/ml 25°C Protect from light
30 Day
3704
Level of evidence C
Not specified Glucose 5% 50 µg/ml 4°C Protect from light
30 Day
3704
Level of evidence C
  Mentions Légales